ID

23551

Description

A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) and Docetaxel in Patients With Inflammatory or Locally Advanced Breast Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00576901

Link

https://clinicaltrials.gov/show/NCT00576901

Keywords

  1. 7/8/17 7/8/17 -
Uploaded on

July 8, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00576901

Eligibility Breast Cancer NCT00576901

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
female patients, >=18 years of age;
Description

Gender | Age

Data type

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
her2-negative, locally advanced (stage ii or iii) or inflammatory cancer of the breast;
Description

Locally advanced breast cancer inflammatory HER2 negative TNM Breast tumor staging

Data type

boolean

Alias
UMLS CUI [1,1]
C3495949
UMLS CUI [1,2]
C0333348
UMLS CUI [1,3]
C4087376
UMLS CUI [1,4]
C0474926
ecog performance status 0-1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
metastatic disease (stage iv);
Description

Neoplasm Metastasis TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C3258246
previous treatment for breast cancer;
Description

Prior Therapy Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0678222
evidence of cns metastasis;
Description

CNS metastases

Data type

boolean

Alias
UMLS CUI [1]
C0686377
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) nsaids or full dose anticoagulants for therapeutic purposes;
Description

Aspirin U/day | Avastin | Anti-Inflammatory Agents, Non-Steroidal | Anticoagulants Dose Full

Data type

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0456683
UMLS CUI [2]
C1135130
UMLS CUI [3]
C0003211
UMLS CUI [4,1]
C0003280
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0443225
clinically significant cardiovascular disease.
Description

Cardiovascular Disease

Data type

boolean

Alias
UMLS CUI [1]
C0007222

Similar models

Eligibility Breast Cancer NCT00576901

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Gender | Age
Item
female patients, >=18 years of age;
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Locally advanced breast cancer inflammatory HER2 negative TNM Breast tumor staging
Item
her2-negative, locally advanced (stage ii or iii) or inflammatory cancer of the breast;
boolean
C3495949 (UMLS CUI [1,1])
C0333348 (UMLS CUI [1,2])
C4087376 (UMLS CUI [1,3])
C0474926 (UMLS CUI [1,4])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Neoplasm Metastasis TNM clinical staging
Item
metastatic disease (stage iv);
boolean
C0027627 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
Prior Therapy Breast Carcinoma
Item
previous treatment for breast cancer;
boolean
C1514463 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
CNS metastases
Item
evidence of cns metastasis;
boolean
C0686377 (UMLS CUI [1])
Aspirin U/day | Avastin | Anti-Inflammatory Agents, Non-Steroidal | Anticoagulants Dose Full
Item
current or recent (within 10 days of first dose of avastin) use of aspirin (>325mg/day) nsaids or full dose anticoagulants for therapeutic purposes;
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C1135130 (UMLS CUI [2])
C0003211 (UMLS CUI [3])
C0003280 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0443225 (UMLS CUI [4,3])
Cardiovascular Disease
Item
clinically significant cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial